The post Argentum AI partners with MolKet to expand into scientific computing and pharmaceutical sectors appeared on BitcoinEthereumNews.com. Argentum AI (AAI), a decentralized compute marketplace based in Chicago, has announced a partnership with MolKet, a scientific computing company focused on quantum molecular simulations.  The collaboration will integrate MolKet’s technology into Argentum AI’s platform, extending its capabilities into the scientific computing and pharmaceutical sectors.  Partnership to accelerate innovation in computational chemistry and drug discovery Under the partnership, MolKet will use Argentum AI’s secure, decentralized infrastructure to offer advanced molecular simulation tools to researchers and organizations globally. The move expands AAI’s compute marketplace beyond AI training to include complex molecular modeling and drug discovery workloads. On the patnership Andrew Sobko, CEO of Argentum AI, said:  “We’re pleased to have MolKet join the Argentum AI platform as a highly innovative company which extends our offerings into quantum simulations. With MolKet’s offerings, Argentum AI is extending both its breadth and depth of utility. We aim to be the world’s most active marketplace for AI, scientific computing, and GPU entrepreneurs.” Clark Alexander, Chief AI Officer of AAI, added:  “This partnership with MolKet shows that Argentum AI is a serious player in the broader scientific computing community. We have moved beyond simply supporting AI training. We now have the ability to run quantum simulations and approach pharmaceuticals on AAI. Partnering with MolKet is a giant step in delivering the world’s most advanced and diverse scientific computing ecosystem to AAI.” MolKet’s quantum molecular simulation technology will be accessible through Argentum AI’s decentralized compute marketplace, enabling affordable and secure access to high-performance simulations for molecular research. “Argentum AI’s distributed compute platform will make computationally intensive scientific simulations affordable and manageable, pushing the limits of physics and quantum simulations. This platform will also empower MolKet’s offerings and software services to run large-scale simulations affordably,” said Taha Selim, General Manager and Co-founder of MolKet.  Alain Chancé, President of… The post Argentum AI partners with MolKet to expand into scientific computing and pharmaceutical sectors appeared on BitcoinEthereumNews.com. Argentum AI (AAI), a decentralized compute marketplace based in Chicago, has announced a partnership with MolKet, a scientific computing company focused on quantum molecular simulations.  The collaboration will integrate MolKet’s technology into Argentum AI’s platform, extending its capabilities into the scientific computing and pharmaceutical sectors.  Partnership to accelerate innovation in computational chemistry and drug discovery Under the partnership, MolKet will use Argentum AI’s secure, decentralized infrastructure to offer advanced molecular simulation tools to researchers and organizations globally. The move expands AAI’s compute marketplace beyond AI training to include complex molecular modeling and drug discovery workloads. On the patnership Andrew Sobko, CEO of Argentum AI, said:  “We’re pleased to have MolKet join the Argentum AI platform as a highly innovative company which extends our offerings into quantum simulations. With MolKet’s offerings, Argentum AI is extending both its breadth and depth of utility. We aim to be the world’s most active marketplace for AI, scientific computing, and GPU entrepreneurs.” Clark Alexander, Chief AI Officer of AAI, added:  “This partnership with MolKet shows that Argentum AI is a serious player in the broader scientific computing community. We have moved beyond simply supporting AI training. We now have the ability to run quantum simulations and approach pharmaceuticals on AAI. Partnering with MolKet is a giant step in delivering the world’s most advanced and diverse scientific computing ecosystem to AAI.” MolKet’s quantum molecular simulation technology will be accessible through Argentum AI’s decentralized compute marketplace, enabling affordable and secure access to high-performance simulations for molecular research. “Argentum AI’s distributed compute platform will make computationally intensive scientific simulations affordable and manageable, pushing the limits of physics and quantum simulations. This platform will also empower MolKet’s offerings and software services to run large-scale simulations affordably,” said Taha Selim, General Manager and Co-founder of MolKet.  Alain Chancé, President of…

Argentum AI partners with MolKet to expand into scientific computing and pharmaceutical sectors

2025/10/23 15:59

Argentum AI (AAI), a decentralized compute marketplace based in Chicago, has announced a partnership with MolKet, a scientific computing company focused on quantum molecular simulations. 

The collaboration will integrate MolKet’s technology into Argentum AI’s platform, extending its capabilities into the scientific computing and pharmaceutical sectors. 

Partnership to accelerate innovation in computational chemistry and drug discovery

Under the partnership, MolKet will use Argentum AI’s secure, decentralized infrastructure to offer advanced molecular simulation tools to researchers and organizations globally. The move expands AAI’s compute marketplace beyond AI training to include complex molecular modeling and drug discovery workloads.

On the patnership Andrew Sobko, CEO of Argentum AI, said: 

Clark Alexander, Chief AI Officer of AAI, added:

MolKet’s quantum molecular simulation technology will be accessible through Argentum AI’s decentralized compute marketplace, enabling affordable and secure access to high-performance simulations for molecular research.

Alain Chancé, President of MolKet, commented: 

Featured image via Shutterstock

Source: https://finbold.com/argentum-ai-partners-with-molket-to-expand-into-scientific-computing-and-pharmaceutical-sectors/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like